<?xml version="1.0" encoding="UTF-8"?>
<ref id="B50-antibiotics-10-00024">
 <label>50.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Teles</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Rosa</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Mouchrek</surname>
    <given-names>A.N.</given-names>
   </name>
   <name>
    <surname>Abreu-Silva</surname>
    <given-names>A.L.</given-names>
   </name>
   <name>
    <surname>Calabrese</surname>
    <given-names>K.D.S.</given-names>
   </name>
   <name>
    <surname>Almeida-Souza</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Cinnamomum zeylanicum, Origanum vulgare, and Curcuma longa essential oils: Chemical composition, antimicrobial and antileishmanial activity</article-title>
  <source>Evid Based Complement Alternat. Med.</source>
  <year>2019</year>
  <volume>2019</volume>
  <fpage>2421695</fpage>
  <pub-id pub-id-type="doi">10.1155/2019/2421695</pub-id>
  <pub-id pub-id-type="pmid">30766611</pub-id>
 </element-citation>
</ref>
